PTHS 8-K 2026-10-01

Pelthos Therapeutics Inc. (PTHS) 8-K dated 2026-10-01 — accession 0001919246-26-000125. This URL is the filing, not the PTHS hub.

Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.

Pelthos Therapeutics Inc. filed a 8-K on 2026-10-01. Accession 0001919246-26-000125.

Cached items: 5.02, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.

Not investment advice. The PTHS SEC hub lists recent forms. The stock page is the research view.